West Pharmaceutical Services, Inc. (NYSE:WST) Q2 2022 Earnings Conference Call July 28, 2022 9:00 AM ET
Company Participants
Quintin Lai – Vice President, Investor Relations
Eric Green – Chief Executive Officer
Bernard Birkett – Chief Financial Officer
Conference Call Participants
Derik de Bruin – Bank of America
Paul Knight – KeyBanc
Larry Solow – CJS Securities
Justin Lin – William Blair
Jacob Johnson – Stephens
Dave Windley – Jefferies
Operator
Good day, and thank you for standing by. Welcome to the Q2 2022 West Pharmaceutical Services Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded.
I would now like to hand the conference over to your speaker for today, Quintin Lai, Vice President, Investor Relations. You may begin.
Quintin Lai
Thank you, Towanda. Good morning, and welcome to West’s second quarter 2022 conference call. We issued our financial results this morning, and the release has been posted in the Investors section on the company’s website located at westpharma.com.
This morning, Eric Green and Bernard Birkett will review our financial results, provide an update on our business and present an update on our financial outlook for the remaining full year of 2022. There is a slide presentation that accompanies today’s call and a copy of that presentation is available on the Investors section of our website.
On Slide 4 is our Safe Harbor statement. Statements made by management on this call and in the accompanying presentation contain forward-looking statements within the meaning of U.S. federal securities law. These statements are based on our beliefs and assumptions, current expectations, estimates and forecasts.
The company’s future results are influenced by many factors beyond the control of the company. Actual results
- Read more current WST analysis and news
- View all earnings call transcripts